Shagun Singh
Stock Analyst at RBC Capital
(3.42)
# 975
Out of 5,090 analysts
242
Total ratings
52.74%
Success rate
2.02%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Outperform | $370 → $380 | $316.45 | +20.08% | 4 | Nov 21, 2025 | |
| MDT Medtronic | Maintains: Outperform | $111 → $118 | $101.99 | +15.70% | 22 | Nov 19, 2025 | |
| OM Outset Medical | Maintains: Sector Perform | $22 → $17 | $4.71 | +260.93% | 14 | Nov 11, 2025 | |
| TFX Teleflex | Maintains: Sector Perform | $135 → $120 | $118.86 | +0.96% | 23 | Nov 7, 2025 | |
| GMED Globus Medical | Maintains: Outperform | $88 → $92 | $88.74 | +3.67% | 6 | Nov 7, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Sector Perform | $211 → $202 | $193.76 | +4.25% | 3 | Nov 7, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $111 → $101 | $93.16 | +8.42% | 17 | Nov 6, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $150 → $125 | $140.03 | -10.73% | 7 | Nov 4, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $89 → $95 | $85.78 | +10.75% | 23 | Oct 31, 2025 | |
| DXCM DexCom | Maintains: Outperform | $100 → $85 | $65.27 | +30.23% | 5 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $615 → $625 | $568.65 | +9.91% | 17 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $147 | $125.40 | +17.22% | 17 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $125 | $97.72 | +27.92% | 17 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $25 | $20.65 | +21.07% | 3 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $330 → $325 | $294.72 | +10.27% | 15 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $185 | $202.48 | -8.63% | 22 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $4 → $3 | $1.06 | +183.02% | 8 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $364.35 | +19.39% | 19 | Jan 29, 2025 |
Insulet
Nov 21, 2025
Maintains: Outperform
Price Target: $370 → $380
Current: $316.45
Upside: +20.08%
Medtronic
Nov 19, 2025
Maintains: Outperform
Price Target: $111 → $118
Current: $101.99
Upside: +15.70%
Outset Medical
Nov 11, 2025
Maintains: Sector Perform
Price Target: $22 → $17
Current: $4.71
Upside: +260.93%
Teleflex
Nov 7, 2025
Maintains: Sector Perform
Price Target: $135 → $120
Current: $118.86
Upside: +0.96%
Globus Medical
Nov 7, 2025
Maintains: Outperform
Price Target: $88 → $92
Current: $88.74
Upside: +3.67%
Becton, Dickinson and Company
Nov 7, 2025
Maintains: Sector Perform
Price Target: $211 → $202
Current: $193.76
Upside: +4.25%
Zimmer Biomet Holdings
Nov 6, 2025
Maintains: Outperform
Price Target: $111 → $101
Current: $93.16
Upside: +8.42%
Inspire Medical Systems
Nov 4, 2025
Maintains: Outperform
Price Target: $150 → $125
Current: $140.03
Upside: -10.73%
Edwards Lifesciences
Oct 31, 2025
Maintains: Outperform
Price Target: $89 → $95
Current: $85.78
Upside: +10.75%
DexCom
Oct 31, 2025
Maintains: Outperform
Price Target: $100 → $85
Current: $65.27
Upside: +30.23%
Oct 22, 2025
Maintains: Outperform
Price Target: $615 → $625
Current: $568.65
Upside: +9.91%
Oct 16, 2025
Reiterates: Outperform
Price Target: $147
Current: $125.40
Upside: +17.22%
Sep 29, 2025
Reiterates: Outperform
Price Target: $125
Current: $97.72
Upside: +27.92%
Aug 7, 2025
Maintains: Outperform
Price Target: $45 → $25
Current: $20.65
Upside: +21.07%
Jul 30, 2025
Maintains: Outperform
Price Target: $330 → $325
Current: $294.72
Upside: +10.27%
Jul 17, 2025
Maintains: Outperform
Price Target: $181 → $185
Current: $202.48
Upside: -8.63%
Jul 15, 2025
Maintains: Sector Perform
Price Target: $4 → $3
Current: $1.06
Upside: +183.02%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $364.35
Upside: +19.39%